semaglutide ckd trial Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT Semaglutides Are Poised to Remake

Understand its role in weight management and if it's right for you.

To mark 50 years of monoclonal antibodies, this Review from Chan, Martyn and Carter provides an overview of how antibody engineering strategies have continued to improve antibody-based therapeutics, chiefly focusing on antibody-mediated targeting of B cells and also human epidermal growth factor receptor 2 (HER2)+ cancers

Peter Attia, Andrew Huberman discusses GLP-1, specifically mentioning its role in weight management and its effects

Big pharma is currently facing a potential bubble effect due to the surging demand for weight loss and diabetes drugs, as revealed in a report by Deloitte released on Monday

avoid freezing the medication

Bre Teamer chats with Dr